咪喹莫特致脱发 1 例。

A case of imiquimod-induced alopecia.

机构信息

Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.

出版信息

J Dermatolog Treat. 2010 Mar;21(2):122-4. doi: 10.1080/09546630902991484.

PMID:19488918

Abstract

Imiquimod cream 5% is an immune modifier approved for the treatment of genital warts, actinic keratosis, and basal cell carcinoma. This case report presents an isolated case of telogen effluvium after 6 weeks of imiquimod treatment for an actinic keratosis on the scalp. Based on this case presentation, telogen effluvium is a potential rare side effect from imiquimod treatment.

摘要

咪喹莫特乳膏 5%是一种免疫调节剂，已获批准用于治疗生殖器疣、光化性角化病和基底细胞癌。本病例报告介绍了一例头皮光化性角化病使用咪喹莫特治疗 6 周后发生休止期脱发的孤立病例。基于该病例报告，休止期脱发是咪喹莫特治疗的一种潜在罕见副作用。